INTRODUCTION
============

Distant metastases to organs such as liver and lung are common in colorectal cancer patients. Approximately 20 percent of patients have liver metastatic disease at the time of presentation.^[@B1]^ Based on autopsy reports, adrenal gland metastasis is also not rare.^[@B2]^ Generally, adrenal metastasis is considered to be a widespread disease and with poor prognosis. Solitary and clinically curable adrenal metastasis from colorectal carcinoma is very rare.^[@B3]^ Here, we present a long-term survival case with rectal cancer and a synchronous solitary adrenal metastasis who underwent radical surgical resection.

CASE REPORT
===========

The patient was a 51-year-old man. A right adrenal mass was found by ultrasonography during his routine physical examination in December 2006. Computed tomography (CT) scan confirmed a moderately enhanced mass in the region of the right adrenal gland, which was 3.3×2.0 cm in size ([Fig.1](#F1){ref-type="fig"}). Furthermore, his serum carcinoembryonic antigen (CEA) level was found elevated at 72.2ng/ml. Gastroscopy and colonoscopy were therefore performed. Colonoscopy revealed a rectal tumor of the ulcerating type located 10cm from anal verge and biopsy specimens confirmed it to be an adenocarcinoma. His chest X-ray and liver CT scan seemed normal. He was subjected to a simultaneous laparoscopic right adrenalectomy and anterior resection for rectal carcinoma on January 5, 2007. No frozen section was done during the procedure. Neither peritoneal seeding nor liver metastasis was observed during intraoperative exploration.

Postoperative pathological examinations showed that the rectal tumor, which measured 4.0×3.0 cm, was a well-differentiated adenocarcinoma that infiltrating to the adventitia layer, with metastasis to two of three dissected lymph nodes. The pathological findings of the right adrenal tumor revealed infiltrating adenocarcinoma within the normal adrenal gland, compatible with metastasis from the rectal carcinoma ([Fig.2](#F2){ref-type="fig"}).

The patient's postoperative course was good; he did not develop adrenal insufficiency and was discharged 14 days after surgery. His serum CEA level normalized to 4.5ng/ml one month postoperatively. Totally, he received 12 cycles of adjuvant chemotherapy with FOLFOX4 schedule. At last follow-up, in January 2013, he showed no evidence of recurrence or metastasis with a normal CT scan and serum CEA, 6 years after resection of his rectal cancer and synchronous solitary adrenal metastasis.

DISCUSSION
==========

The incidence of adrenal metastasis from colorectal carcinoma ranges from 0.15% to 17.4% with a mean percentage of 16%.^[@B4]^ Metastatic adrenal disease is usually part of a disease disseminated to several organs and has limited survival. Solitary adrenal disease is infrequent and always in a metachronous setting. Some of the reported cases include patients who had other distant metastases before the adrenal metastasis; strictly speaking, such patients might not be considered to have a solitary metastasis. By performing a Medline literature search, we were able to identify 16 previous reported cases of resection of solitary adrenal metastasis from colorectal carcinoma ([Table-I](#T1){ref-type="table"}). Only 6 of these 17 cases, including ours, the metastasis was synchronous.

Since 15 of 17 cases were male patients, solitary adrenal metastasis seems more frequently in male; with an average age over 61 (range 43-74). The primary carcinomas were mostly in rectum (10 cases), others were in sigmoid colon (3 cases), ascending colon (2 cases), descending colon (1 case) and cecum (1 case).

![Enhanced CT scan demonstrating a right adrenal mass of low density](pjms-30-216-g001){#F1}

![Microscopic appearance of the adrenal tumor showing a well-differentiated adenocarcinoma, similar to the primary rectal carcinoma (H&E ×100).](pjms-30-216-g002){#F2}

###### 

Total 17 cases of solitary adrenal metastasis from colorectal carcinoma

  *Author, year*     *Patient data*   *Colorectal carcinoma*   *Adrenal metastasis*   *Recurrence*   *Outcome*                                           
  ------------------ ---------------- ------------------------ ---------------------- -------------- ----------- ------- ------------- ----------- ----- -----------------
  Matsui, 1985       1                71                       M                      Rectum         B           2y      10×6.5×6.5    None        \-    Alive at 8m
  Watatani, 1993     2                52                       M                      Rectum         D           Syn     10.5×6×5      Liver       6m    Died at2y9m
  Watatani, 1993     3                66                       M                      Cecum          C           1y 6m   9×8           None        \-    Alive at 1y
  Fujii, 1994        4                57                       M                      Ascending      B           3y 1m   6×4×3         None        \-    Alive at 9y
  Mizutani, 1995     5                58                       M                      Rectum         B           1y 2m   4.0×3.5×2.0   Lung        4m    Died at 2y 7m
  Kamasako, 1995     6                71                       F                      Sigmoid        D           Syn     6.5×5.0×3.5   Liver       8m    Alive at 11m
  Ozawa, 1996        7                46                       M                      Descending     C           1y 2m   10×9.1×5.7    None        \-    Alive at 1y 2m
  Shoji, 2006        8                73                       M                      Sigmoid        B           4m      5.3×3.3×2.4   Liver       12m   Died at 3y 2m
  Kita, 2006         9                45                       M                      Rectum         D           Syn     ?             None        \-    Alive at 1y
  Mourra, 2008       10               56                       M                      Rectum         D           Syn     1.8           None        \-    Alive at 1y 10m
  Mourra, 2008       11               61                       M                      Rectum         B           3y      3.0           Lung        ?     Died at 2y
  Mourra, 2008       12               66                       M                      Rectum         A           5y      15            Liver       ?     Died at 4y
  Bonfill, 2009      13               61                       F                      Rectum         D           Syn     6             None        \-    Alive at 5y
  Pascual, 2010      14               65                       M                      Rectum         ?           9m      6.8           Bilateral   8m    Alive at 2y 10m
  Thrumurthy, 2011   15               68                       M                      Sigmoid        B           1y      6×5×2         Bilateral   7m    Alive at 8y
  Capaldi,2011       16               74                       M                      Ascending      B           3y 8m   4×5           None        \-    Alive at 10m
  Our case           17               51                       M                      Rectum         D           Syn     3.3×2.0       None        \-    Alive at 6y

M: male; F: female; Syn: synchronous; y: years; m: months; ?: unknown (not described).

In all cases, patients with metastatic adrenal tumor were asymptomatic, without pain or adrenal insufficiency. All metastases were diagnosed by CT scan or elevation in CEA levels synchronously or in follow-up surveillance. Serum CEA level is a useful indicator for the presence of adrenal metastases. In most of the cases, including ours, CEA levels were elevated at the time of adrenal metastasis and decreased considerably after adrenalectomy. Only in one case (case 16), CEA level remained within the normal range. CT scan is a cost-effective means of identifying adrenal metastases. The findings of CT in our patient disclosed the low density of the adrenal gland, in accordance with reports by other authors.^[@B5],[@B6]^ However, it does not provide any distinction between primary lesions and secondary lesions. Magnetic resonance imaging (MRI) is reported effective for distinguishing adenomas, carcinomas, and metastases in case of adrenal incidentaloma.^[@B6]^ Recently, A few reports and studies in the literature have suggested that fluorine 18-fluoro-deoxy-glucose positron emission tomography (18F-FDG PET-CT) is useful to differentiate benign from malignant adrenal lesions, with sensitivity ranging from 93 to 100%, specificity ranging from 80 to 100% and accuracy ranging from 92 to 100%**.**^[@B7]^ Although PET-CT was not performed preoperatively in our patient, we think it is useful to exclude metastatic disease elsewhere prior to a potentially curative adrenal resection. Candel et al.^[@B8]^ emphasized that fine-needle aspiration biopsy of adrenal masses was helpful for making an accurate diagnosis. However, in our opinion, this risky technique in characterizing adrenal masses, may eventually be assumed by the less invasive and more accurate PET-CT.

It is thought that there are several routes by which colorectal cancer can metastasize to the adrenal glands, including systemic venous, portal venous, arterial and lymphatic routes. The 4 latent liver metastases (case 2, 6, 8, 12) and 2 latent lung metastases (case 5, 11) 4-12 months after adrenalectomy might suggest that the route from primary lesion via liver or lungs to systemic venous circulation and silent liver or lung metastases had already occurred at the time of detection of the adrenal metastases. In contrast, there were 3 patients, including ours (2 synchronous, 1 metachronous, case 4, 13, 17) had no other metastases detected during the long-term (\>5 years) follow-up.

The follow-up period of the 17 patients after resection of adrenal metastases ranged from 8 months to 9 years. Five patients died of recurrence with extensive metastases to multiple organs 24-48 months (median 33 months) after adrenalectomy. One patient showed liver recurrence 8 months after adrenalectomy, but was still alive at the time of report. Two patients presented metachronous bilateral adrenal metastases, after operations, they were alive without metastatic and recurrent disease at the time of report. Nine patients were alive without signs of recurrence 8 months-9 years after adrenalectomy (median follow-up period of 14 months). In the 6 synchronous adrenal metastases patients, 4, including ours, were alive without signs of recurrence at the time of report. These data suggest that resection of solitary adrenal metastasis from colorectal carcinoma may improve patients' chances of survival. Our long-term survival case also suggests that synchronous solitary adrenal metastasis may respond well to radical surgical resection, chemotherapy and vigilant follow-up.

With technological advances, laparoscopic adrenalectomy is now considered as the gold-standard approach for small benign secreting tumors, but it remains a matter of debate for large and potentially malignant adrenal tumors and adrenal metastases.^[@B9]^ Recently, several reports have described long-term survival after laparoscopic adrenalectomy for solitary adrenal metastasis^.[@B10],[@B11]^ However, no prospective randomized studies have compared open versus laparoscopic resection of solitary adrenal metastasis, because it is difficult to recruit patients. In our case, since the adrenal mass was relatively small (3.3×2.0 cm) and no signs of invasion of the surrounding organs or lymph nodes, we performed laparoscopic approach. It suggests that laparoscopic adrenalectomy for small solitary metastasis is a feasible procedure.

In conclusion, synchronous solitary adrenal metastasis from colorectal carcinoma is very rare. On the basis of our case and international literature, we believe that surgical resection and for selected patients, laparoscopic procedure may provide survival benefit and potential surgical cure for a solitary metastasis.
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